Potential Molecular Pathways Related to Pulmonary Artery Aneurysm Development: Lessons to Learn from the Aorta

Pulmonary arterial hypertension (PAH) is a rare disease caused by pulmonary vascular remodeling. Current vasodilator treatments have substantially improved patients’ survival. This improved survival has led to the appearance of complications related to conditions previously underdiagnosed or even ig...

Full description

Bibliographic Details
Main Authors: Jorge Nuche, Julián Palomino-Doza, Fernando Arribas Ynsaurriaga, Juan F. Delgado, Borja Ibáñez, Eduardo Oliver, Pilar Escribano Subías
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/7/2509
id doaj-db44b00b5f574211b3fd6b6b871e6214
record_format Article
spelling doaj-db44b00b5f574211b3fd6b6b871e62142020-11-25T03:01:16ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-04-01212509250910.3390/ijms21072509Potential Molecular Pathways Related to Pulmonary Artery Aneurysm Development: Lessons to Learn from the AortaJorge Nuche0Julián Palomino-Doza1Fernando Arribas Ynsaurriaga2Juan F. Delgado3Borja Ibáñez4Eduardo Oliver5Pilar Escribano Subías6Centro de Investigaciones Biomédicas en Red de enfermedades CardioVasculares (CIBERCV), 28029 Madrid, SpainCentro de Investigaciones Biomédicas en Red de enfermedades CardioVasculares (CIBERCV), 28029 Madrid, SpainCentro de Investigaciones Biomédicas en Red de enfermedades CardioVasculares (CIBERCV), 28029 Madrid, SpainCentro de Investigaciones Biomédicas en Red de enfermedades CardioVasculares (CIBERCV), 28029 Madrid, SpainCentro de Investigaciones Biomédicas en Red de enfermedades CardioVasculares (CIBERCV), 28029 Madrid, SpainCentro de Investigaciones Biomédicas en Red de enfermedades CardioVasculares (CIBERCV), 28029 Madrid, SpainCentro de Investigaciones Biomédicas en Red de enfermedades CardioVasculares (CIBERCV), 28029 Madrid, SpainPulmonary arterial hypertension (PAH) is a rare disease caused by pulmonary vascular remodeling. Current vasodilator treatments have substantially improved patients’ survival. This improved survival has led to the appearance of complications related to conditions previously underdiagnosed or even ignored, such as pulmonary artery aneurysm (PAA). The presence of a dilated pulmonary artery has been shown to be related to an increased risk of sudden cardiac death among PAH patients. This increased risk could be associated to the development of left main coronary artery compression or pulmonary artery dissection. Nevertheless, very little is currently known about the molecular mechanisms related to PAA. Thoracic aortic aneurysm (TAA) is a well-known condition with an increased risk of sudden death caused by acute aortic dissection. TAA may be secondary to chronic exposure to classic cardiovascular risk factors. In addition, a number of genetic variants have been shown to be related to a marked risk of TAA and dissection as part of multisystemic syndromes or isolated familial TAA. The molecular pathways implied in the development of TAA have been widely studied and described. Many of these molecular pathways are involved in the pathogenesis of PAH and could be involved in PAA. This review aims to describe all these common pathways to open new research lines that could help lead to a better understanding of the pathophysiology of PAH and PAA and their clinical implications.https://www.mdpi.com/1422-0067/21/7/2509molecular biologygenepulmonary arterial hypertensionpulmonary artery aneurysmaortic aneurysm
collection DOAJ
language English
format Article
sources DOAJ
author Jorge Nuche
Julián Palomino-Doza
Fernando Arribas Ynsaurriaga
Juan F. Delgado
Borja Ibáñez
Eduardo Oliver
Pilar Escribano Subías
spellingShingle Jorge Nuche
Julián Palomino-Doza
Fernando Arribas Ynsaurriaga
Juan F. Delgado
Borja Ibáñez
Eduardo Oliver
Pilar Escribano Subías
Potential Molecular Pathways Related to Pulmonary Artery Aneurysm Development: Lessons to Learn from the Aorta
International Journal of Molecular Sciences
molecular biology
gene
pulmonary arterial hypertension
pulmonary artery aneurysm
aortic aneurysm
author_facet Jorge Nuche
Julián Palomino-Doza
Fernando Arribas Ynsaurriaga
Juan F. Delgado
Borja Ibáñez
Eduardo Oliver
Pilar Escribano Subías
author_sort Jorge Nuche
title Potential Molecular Pathways Related to Pulmonary Artery Aneurysm Development: Lessons to Learn from the Aorta
title_short Potential Molecular Pathways Related to Pulmonary Artery Aneurysm Development: Lessons to Learn from the Aorta
title_full Potential Molecular Pathways Related to Pulmonary Artery Aneurysm Development: Lessons to Learn from the Aorta
title_fullStr Potential Molecular Pathways Related to Pulmonary Artery Aneurysm Development: Lessons to Learn from the Aorta
title_full_unstemmed Potential Molecular Pathways Related to Pulmonary Artery Aneurysm Development: Lessons to Learn from the Aorta
title_sort potential molecular pathways related to pulmonary artery aneurysm development: lessons to learn from the aorta
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1661-6596
1422-0067
publishDate 2020-04-01
description Pulmonary arterial hypertension (PAH) is a rare disease caused by pulmonary vascular remodeling. Current vasodilator treatments have substantially improved patients’ survival. This improved survival has led to the appearance of complications related to conditions previously underdiagnosed or even ignored, such as pulmonary artery aneurysm (PAA). The presence of a dilated pulmonary artery has been shown to be related to an increased risk of sudden cardiac death among PAH patients. This increased risk could be associated to the development of left main coronary artery compression or pulmonary artery dissection. Nevertheless, very little is currently known about the molecular mechanisms related to PAA. Thoracic aortic aneurysm (TAA) is a well-known condition with an increased risk of sudden death caused by acute aortic dissection. TAA may be secondary to chronic exposure to classic cardiovascular risk factors. In addition, a number of genetic variants have been shown to be related to a marked risk of TAA and dissection as part of multisystemic syndromes or isolated familial TAA. The molecular pathways implied in the development of TAA have been widely studied and described. Many of these molecular pathways are involved in the pathogenesis of PAH and could be involved in PAA. This review aims to describe all these common pathways to open new research lines that could help lead to a better understanding of the pathophysiology of PAH and PAA and their clinical implications.
topic molecular biology
gene
pulmonary arterial hypertension
pulmonary artery aneurysm
aortic aneurysm
url https://www.mdpi.com/1422-0067/21/7/2509
work_keys_str_mv AT jorgenuche potentialmolecularpathwaysrelatedtopulmonaryarteryaneurysmdevelopmentlessonstolearnfromtheaorta
AT julianpalominodoza potentialmolecularpathwaysrelatedtopulmonaryarteryaneurysmdevelopmentlessonstolearnfromtheaorta
AT fernandoarribasynsaurriaga potentialmolecularpathwaysrelatedtopulmonaryarteryaneurysmdevelopmentlessonstolearnfromtheaorta
AT juanfdelgado potentialmolecularpathwaysrelatedtopulmonaryarteryaneurysmdevelopmentlessonstolearnfromtheaorta
AT borjaibanez potentialmolecularpathwaysrelatedtopulmonaryarteryaneurysmdevelopmentlessonstolearnfromtheaorta
AT eduardooliver potentialmolecularpathwaysrelatedtopulmonaryarteryaneurysmdevelopmentlessonstolearnfromtheaorta
AT pilarescribanosubias potentialmolecularpathwaysrelatedtopulmonaryarteryaneurysmdevelopmentlessonstolearnfromtheaorta
_version_ 1724693983443025920